Viscosupplementation treatment of arthritis pain

  • Michael Benke
  • Benjamin Shaffer


With the aging of the baby boomer generation, the number of patients with osteoarthritis (OA) is expected to swell, posing treatment challenges. Viscosupplementation, in which hyaluronic acid (HA) is injected into the knee joint, has evolved into an important part of our current therapeutic regimen in addressing the patient with knee pain due to OA. Although suffering from lack of an “evidence-based” approach, and largely funded by industry, there is a growing body of outcome data demonstrating the efficacy of HA in decreasing pain and improving function in patients with knee OA, although no evidence indicates that HA is in any way chondroprotective. The clinical success of HA has led to the ongoing introduction of various forms of HA, although little data are available to justify one over the other.


Hyaluronic Acid Osteoarthritis Cartilage Weekly Injection Arthroscopic Debridement Calcium Pyrophosphate Dihydrate 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References and Recommended Reading

  1. 1.
    Liberati A: Meta-analysis: statistical alchemy for the 21st century: discussion. A plea for a more balanced view of meta-analysis and systematic overviews of the effect of health care interventions. J Clin Epidemiol 1995, 48:81–86.CrossRefPubMedGoogle Scholar
  2. 2.
    Smalley WE, Griffin MR, Fought RL, et al.: Excess costs from gastrointestinal disease associated with nonsteroidal anti-inflammatory drugs. J Gen Intern Med 1996, 11:461–469.CrossRefPubMedGoogle Scholar
  3. 3.
    Stitik TP, Levy JA: Viscosupplementation (biosupplementation) for osteoarthritis. Am J Phys Med Rehabil 2006, 85(Suppl 11):S32–S50.CrossRefPubMedGoogle Scholar
  4. 4.
    Balazs EA, Denlinger JL: Viscosupplementation: a new concept in the treatment of osteoarthritis. J Rheumatol 1993, 20(Suppl 39):3–9.Google Scholar
  5. 5.
    Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines. Arthritis Rheum 2000, 43:1905–1915.Google Scholar
  6. 6.
    Kelly MA, Goldberg VM, Healy WL, et al.: Osteoarthritis and beyond: a consensus on the past, present, and future of hyaluronans in orthopedics. Orthopedics 2003, 26:1064–1081.PubMedGoogle Scholar
  7. 7.
    Fraser JRE, Clarris BJ, Baxter EP: Patterns of induced variation in the morphology, hyaluronic acid secretion, and lysosomal enzyme activity of cultured human synovial cells. Ann Rheum Dis 1979, 38:287–294.CrossRefPubMedGoogle Scholar
  8. 8.
    Balazs EA, Bland PA, Denlinger JL, et al.: Matrix engineering. Blood Coagul Fibrinolysis 1991, 2:173–177.CrossRefPubMedGoogle Scholar
  9. 9.
    Kolarz G, Kotz R, Hochmayer I: Long-term benefits and repeated treatment cycles of intra-articular sodium hyaluronate (Hyalgan) in patients with osteoarthritis of the knee. Semin Arthritis Rheum 2003, 32:310–319.CrossRefPubMedGoogle Scholar
  10. 10.
    Weiss C, Suros J, Dennis J, et al.: Effect of Na-hylan on articular cartilage. Proceedings of the Orthopedic Research Society. Las Vegas; 1989:539.Google Scholar
  11. 11.
    Fraser JRE, Kimpton WG, Pierscionek BK, et al.: The kinetics of hyaluronan in normal and acutely inflamed synovial joints: observations with experimental arthritis in sheep. Semin Arthritis Rheum 1993, 22(6 Suppl 1):9–17.PubMedGoogle Scholar
  12. 12.
    Tamoto K, Tada M, Shimada S, et al.: Effects of high-molecular weight hyaluronates on the functions of guinea pig polymorphonuclear leukocytes. Semin Arthritis Rheum 1993, 22(6 Suppl 1):4–8.PubMedGoogle Scholar
  13. 13.
    Culty M, Miyake K, Kincade PW, et al.: The hyaluronate receptor is a member of the CD44 (H-CAM) family of cell surface glycoproteins. J Cell Biol 1990, 111:2765–2774.CrossRefPubMedGoogle Scholar
  14. 14.
    Forrester JV, Balazs EA: Inhibition of phagocytosis by high molecular weight hyaluronate. Immunology 1980, 40:435–446.PubMedGoogle Scholar
  15. 15.
    Håkansson L, Hällgren R, Venge P: Regulation of granulocyte function by hyaluronic acid: in vitro and in vivo effects on phagocytosis, locomotion, and metabolism. J Clin Invest 1980, 66:298–305.CrossRefPubMedGoogle Scholar
  16. 16.
    Greenberg DD, Stoker A, Kane S, et al.: Biochemical effects of two different hyaluronic acid products in a co-culture model of osteoarthritis. Osteoarthritis Cartilage 2006, 14:814–822.CrossRefPubMedGoogle Scholar
  17. 17.
    Comer JS, Kincaid SA, Baird AN, et al.: Immunolocalization of stromelysin, tumor necrosis factor (TNF) alpha, and TNF receptors in atrophied canine articular cartilage treated with hyaluronic acid and transforming growth factor beta. Am J Vet Res 1996, 57:1488–1496.PubMedGoogle Scholar
  18. 18.
    Takahashi K, Goomer RS, Harwood F, et al.: The effects of hyaluronan on matrix metalloproteinase-3 (MMP-3), interleukin-1beta (IL-1beta), and tissue inhibitor of metalloproteinase-1 (TIMP-1) gene expression during the development of osteoarthritis. Osteoarthritis Cartilage 1999, 7:182–190.CrossRefPubMedGoogle Scholar
  19. 19.
    Dougados M, Nguyen M, Listrat V, et al.: High molecular weight sodium hyaluronate in knee OA. 1-year placebo-controlled trial. Osteoarthritis Cartilage 1993, 1:97–103.CrossRefPubMedGoogle Scholar
  20. 20.
    Smith MM, Ghosh P: The synthesis of hyaluronic acid by human synovial fibroblasts is influenced by the nature of the hyaluronate in the extracellular environment. Rheumatol Int 1987, 7:113–122.CrossRefPubMedGoogle Scholar
  21. 21.
    Vuorio E, Einola S, Hakkarainen S, et al.: Synthesis of under-polymerised hyaluronic acid by fibroblasts cultured from rheumatoid and non-rheumatoid synovitis. Rheumatol Int 1982, 2:97–102.CrossRefPubMedGoogle Scholar
  22. 22.
    Aihara S, Murakami N, Ishii R, et al.: Effects of sodium hyaluronate on the nociceptive response of rats with experimentally induced arthritis [in Japanese]. Nippon Yakurigaku Zasshi 1992, 100:359–365.PubMedGoogle Scholar
  23. 23.
    Moore AR, Willoughby DA: Hyaluronan as a drug delivery system for diclofenac: a hypothesis for mode of action. Int J Tissue React 1995, 17:153–156.PubMedGoogle Scholar
  24. 24.
    Watterson JR, Esdaile JM: Viscosupplementation: therapeutic mechanisms and clinical potential in osteoarthritis of the knee. J Am Acad Orthop Surg 2000, 8:277–284.PubMedGoogle Scholar
  25. 25.
    Listrat V, Ayral X, Patamello F, et al.: Arthroscopic evaluation of potential structure modifying activity of hyaluronan in osteoarthritis of the knee. Osteoarthritis Cartilage 1997, 5:153–160.CrossRefPubMedGoogle Scholar
  26. 26.
    Frizziero L, Govoni E, Bacchini P: Intra-articular hyaluronic acid in the treatment of osteoarthritis of the knee: clinical and morphological study. Clin Exp Rheumatol 1998, 16:441–449.PubMedGoogle Scholar
  27. 27.
    Jubb RW, Piva S, Beinat L, et al.: A randomized, placebo (saline)-controlled clinical trial of the structure modifying effect of 500–730 KDa sodium hyaluronate (Hyalgan) in osteoarthritis of the knee. Int J Clin Pract 2003, 57:467–474.PubMedGoogle Scholar
  28. 28.
    Wang CT, Lin J, Chang CJ, et al.: Therapeutic effects of hyaluronic acid on osteoarthritis of the knee: a meta-analysis of randomized controlled trials. J Bone Joint Surg Am 2004, 86:538–545.PubMedGoogle Scholar
  29. 29.
    Jackson DW, Evans NA, Thomas BM: Accuracy of needle placement into the intra-articular space of the knee. J Bone Joint Surg Am 2002, 84:1522–1527.PubMedGoogle Scholar
  30. 30.
    Esenyel C, Demirhan M, Esenyel M, et al.: Comparison of four different intra-articular injection sites in the knee: a cadaver study. Knee Surg Sports Traumatol Arthrosc 2007, 15:573–577.CrossRefPubMedGoogle Scholar
  31. 31.
    Bellamy N, Campbell J, Robinson V, et al.: Viscosupplementation for the treatment of osteoarthritis of the knee. Cochrane Database Syst Rev 2005, 2:CD005321.PubMedGoogle Scholar
  32. 32.
    Modawal A, Ferrer M, Choi HK, et al.: Hyaluronic acid injections relieve knee pain. J Fam Pract 2005, 54:758–767.PubMedGoogle Scholar
  33. 33.
    Arrich J, Piribauer F, Mad P, et al.: Intra-articular hyaluronic acid for the treatment of osteoarthritis of the knee: systematic review and meta-analysis. CMAJ 2005, 172:1039–1043.PubMedGoogle Scholar
  34. 34.
    Lo GH, LaValley M, McAlindon T, et al.: Intra-articular hyaluronic acid in treatment of knee osteoarthritis: a metaanalysis. JAMA 2003, 290:3115–3121.CrossRefPubMedGoogle Scholar
  35. 35.
    Scali JJ: Intra-articular hyaluronic acid in the treatment of osteoarthritis of the knee: a long-term study. Eur J Rheumatol Inflamm 1995, 15:57–62.Google Scholar
  36. 36.
    Waddell DD, Cefalu CA, Bricker DC: A second course of hylan G-F 20 for the treatment of osteoarthritic knee pain: 12-month patient follow-up. J Knee Surg 2005, 18:7–15.PubMedGoogle Scholar
  37. 37.
    Peyron JG: Intraarticular hyaluronan injections in the treatment of osteoarthritis: state-of-the-art review. J Rheumatol 1993, 20(Suppl 39):10–15.Google Scholar
  38. 38.
    Puttick MPE, Wade JR, Chalmers A, et al.: Acute local reactions after intraarticular hylan for osteoarthritis of the knee. J Rheumatol 1995, 22:1311–1314.PubMedGoogle Scholar
  39. 39.
    Lussier A, Cividino AA, McFarlane CA, et al.: Viscosupplementation with hylan for treatment of osteoarthritis: findings from clinical practice in Canada. J Rheumatol 1996, 23:1579–1585.PubMedGoogle Scholar
  40. 40.
    Goldberg VM, Coutts RD: Pseudoseptic reactions to hylan viscosupplementation: diagnosis and treatment. Clin Orthop Relat Res 2004, 419:130–137.CrossRefPubMedGoogle Scholar
  41. 41.
    Hamburger MI, Lakhanpal S, Mooar PA, et al.: Intraarticular hyaluronans: a review of product-specific safety profiles. Semin Arthritis Rheum 2003, 32:296–309.CrossRefPubMedGoogle Scholar
  42. 42.
    Valiveti M, Reginato AJ, Falasca GF: Viscosupplementation for degenerative disease of the shoulder and ankle. J Clin Rheum 2006, 12:162–163.CrossRefGoogle Scholar
  43. 43.
    Carpenter B, Motley T: The role of viscosupplementation in the ankle using hylan G-F 20. J Foot Ankle Surg 2008, 47:377–384.CrossRefPubMedGoogle Scholar
  44. 44.
    Luciani D, Cadossi M, Tesei F, et al.: Viscosupplementation for grade II osteoarthritis of the ankle: a prospective study at 18 months’ follow-up. Chir Organi Mov 2008, 92:155–160.CrossRefPubMedGoogle Scholar
  45. 45.
    Abate M, Pelotti P, De Amicis D, et al.: Viscosupplementation with hyaluronic acid in hip osteoarthritis (a review). Ups J Med Sci 2008, 113:261–277.CrossRefPubMedGoogle Scholar
  46. 46.
    Van Brakel RW, Eygendaal D: Intra-articular injection of hyaluronic acid is not effective for the treatment of posttraumatic osteoarthritis of the elbow. Arthroscopy 2006, 22:1199–1203.PubMedGoogle Scholar
  47. 47.
    Atay T, Aslan A, Baydar ML: The efficacy of low- and high-molecular-weight hyaluronic acid applications after arthroscopic debridement in patients with osteoarthritis of the knee. Acta Orthop Traumatol Turc 2008, 42:228–233.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2009

Authors and Affiliations

  1. 1.Department of OrthopaedicsGeorge Washington UniversityWashington, DCUSA

Personalised recommendations